Firefly Neuroscience (AIFF) Return on Equity (2011 - 2026)

Firefly Neuroscience has reported Return on Equity for 14 years, with the latest figure at 0.01% in Q1 2026.

• For the quarter ending Q1 2026, Return on Equity rose 6.0% year-over-year to 0.01%; the trailing twelve-month figure through Mar 2026 stood at 0.01% (up 6.0% YoY), and the FY2025 full-year result was 0.05%, down 12.0% from the prior year.
• Return on Equity for Q1 2026 stood at 0.01%, up from 0.02% in the prior quarter.
• The five-year high for Return on Equity was 0.06% in Q3 2023, with the low at 1.57% in Q1 2023.
• Average Return on Equity over 5 years is 0.13%, with a median of 0.01% recorded in 2026.
• Peak annual rise in Return on Equity reached 6 bps in 2023, while the deepest fall reached 157 bps in 2023.
• Tracing AIFF's Return on Equity over 5 years: stood at 0.02% in 2022, then soared by 90 bps to 0.0% in 2023, then surged by 1344 bps to 0.03% in 2024, then slumped by 184 bps to 0.02% in 2025, then jumped by 52 bps to 0.01% in 2026.
• The last three Return on Equity figures came in at 0.01% (Q1 2026), 0.02% (Q4 2025), and 0.02% (Q3 2025), per Business Quant data.

Peer Comparison